Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in REPL — Replimune Group, Inc.

CIK 902219 Boston, MA
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,383,392
+$871,922 QoQ
Shares Held
215,302
+9.0% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 199 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 0% Shared 70% None 30%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. REPL ranks #110 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in REPL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,383,392 215,302
2026-03-31 $1,511,470 197,578
2025-12-31 $2,028,261 208,669
2025-09-30 $951,196 227,016
2025-06-30 $8,774,459 944,506
2025-03-31 $9,129,508 936,360
2024-12-31 $13,281,567 1,096,744
2024-09-30 $2,656,681 242,398
2024-06-30 $3,649,644 405,516
2024-03-31 $2,530,893 309,779
2023-12-31 $2,079,039 246,624
2023-09-30 $4,470,448 261,277
2023-06-30 $4,844,713 208,644
2023-03-31 $2,563,278 145,146
2022-12-31 $7,733,096 284,305
2022-09-30 $457,015 26,463
2022-06-30 $782,387 44,759
2022-03-31 $760,007 44,759
2021-12-31 $6,646,301 245,251
2021-09-30 $10,848,505 366,009
2021-06-30 $14,081,006 366,502